Introduction
Salivary adenoid cystic carcinoma (SACC) is a rare tumor and accounts for less than 1% of all malignant head and neck tumors [1] . It most frequently arises in the salivary gland, both major (parotid gland, submandibular gland, sublingual gland) as well as minor salivary glands. As a kind of epithelial tumor, it most commonly occurs in 40-60 year old adults [2, 3] . It's growth pattern along the nerves and higher incidence of distant metastasis [4] results in a poor prognosis for these patients [3] . Like other tumors, it is certain that the interaction of tumor suppressor and oncogenes play a vital role in the pathophysiology of SACC. However, precise mechanisms responsible for SACC carcinogenesis are not yet fully understood [5] .
Oncogenic kinases such as Pim kinases are known to phosphorylate numerous substrates in order to exert their functions. They play important roles in many malignancies. Pim-1 is up-regulated in hematopoietic cancers [6] and solid malignancies such as gastric [7] , prostate [8] , esophageal squamous cell [9] , breast [10] , lung [11] , and colon cancer [12] . Pim kinases are involved in cancer-specific pathways including cell survival, cell cycle progression and cell migration, thus representative of interesting targets for new drug development. In our previous study, we demonstrated the oncogenic role of Pim-1 in SACC by using siRNA knockdown in SACC-83 and SACC-LM cell lines [13] . Due to its oncogenic role in cancer, suppression of Pim-1 activity may benefit in SACC treatment strategies.
Several novel small-molecule inhibitors with various chemical structures targeting Pim-1 kinases have been investigated and have received increasing research interest. SGI-1776 is the first clinically tested inhibitor of the Pim kinase family [14, 15] . SGI-1776, an imidazo [1,2-b] pyridazine small organic molecule, inhibits Pim-1 by competitively binding with ATP. It has been suggested in several reports that SGI-1776 can reduce Pim-1 expression and affect cellular events such as cell proliferation, apoptosis, cell cycle and invasion [16] [17] [18] [19] [20] [21] . In this study, we examined the effects of SGI-1776 on expression of Pim-1 and related proteins, Pim-1 kinase activity, cell proliferation, cell cycle, invasion, migration and apoptosis in SACC-83 and SACC-LM cell lines.
Materials and methods

Quantitative real-time reverse transcription-PCR
Thirty-five fresh frozen SACC and twenty-seven para-cancerous histological normal fresh frozen specimens were collected in Zhejiang Province Cancer Hospital between August 2006 and May 2013 for RNA extraction. All tissues were homogenized by TissueLyser II (Qiagen) at 18 Hz for 2 min according to the manufacturer's protocol. Trizol (Invitrogen, Carlsbad, CA, USA) was used to extract total RNA and PrimeScipt TM RT reagent Kit (Takara Bio, Otsu, Japan) was used for reverse transcription according to the manufacturer's protocol. qRT-PCR reaction was performed in the ABI Prism 7500 PCR system(Applied Biosystems, Foster city, CA, USA) with the help of SYBR Premix Ex Taq (Takara Bio, Otsu, Japan), in accordance with the manufacturer's instructions. The primer sequences for Pim-1 mRNA were (F) 5′-CTGCTCAAGGACACCGTCTACA-3′ and (R)5′-GATGGTAGCGGATCCA CTCTG-3′. The primers for GAPDH were (F) 5′-GAAGGTGAAG GTCGGAGTC-3′ and (R)) 5′-GAAGATGGTGATGGGATTTC-3′. Each PCR reaction was performed in triplicate parallel holes. 2 -△△Ct method was used to evaluate the Pim-1 mRNA expression.
Cell culture
SACC-83 and SACC-LM cells were kindly gifted by Prof. Shengling Li (Peking University School of Stomatology). SACC-83 cell line was originated from human ACC tissue. SACC-LM is a lung metastatic cell line of SACC-83 and considered to be more malignant than SACC-83 [22, 23] . Both cell lines were maintained in RPMI-1640 (Gibco, USA) with 10% fetal bovine serum (FBS) (Gibco, USA) in a humidified atmosphere of 5% CO2 at 37°C. SACC-83 and SACC-LM cells were seeded in a 6-well plate with a density of 1×10 5 cells/well for treatment and downstream analysis.
SGI-1776 treatment
SGI-1776 was obtained from Selleckchem (Houston, TX, USA). It was dissolved in DMSO and stocked at 10 mM at −80°C. 24 h after seeding, SACC-83 and SACC-LM cells were treated with SGI-1776 at final concentration of 2.5 μM or 5 μM for 72 h. 0 μM SGI-1776 as the control group. The highest concentration of DMSO in the cultivating environment was 0.05%, which was confirmed to have no cytotoxic effect on cell viability.
Pim-1 kinase assay
SACC-83 and SACC-LM cells of 0 μM, 2.5 μM and 5 μM groups after SGI-1776 exposure were harvested. Pim-1 kinase activity was assayed by the Pim-1 Kinase (Human) Assay/Inhibitor Screening Assay Kit (Heidelberg, Germany, Cat # KA0069) according to the supplier's protocol. 6 samples of SACC cells were diluted in Kinase buffer and pipetted into the wells which was pre-coated with a substrate corresponding to recombinant p21waf1. It contains threonine residues that can be efficiently phosphorylated by Pim-1. After undergoing the procedure described in the protocol, measure absorbance in each well was quantitated by spectrophotometry at dual wavelengths of 450/ 540 nm. It reflected the relative amount of Pim-1 activity in the 6 groups of SACC cells.
Colony formation assay
After SGI-1776 treatment, SACC-83 and SACC-LM cells of 0 μM, 2.5 μM and 5 μM groups were washed with Phosphate Buffered Saline (PBS) and released with trypsin. Then, cells were seeded into a 12-well plate at a density of 1000 cells/well. Colonies were stained by 0.5% crystal violet (Beyotime, Nanjing, China) after 7 days of culture.
Evaluation of apoptosis
Annexin V: FITC Apoptosis Detection Kit (BD Biosciences, USA) was used to distinguish intact, dead, and apoptotic cells using flow cytometry. After exposure to SGI-1776 for 72 h, SACC-83 and SACC-LM cells of 0 μM, 2.5 μM and 5 μM groups were harvested. Cold PBS was used to wash the cells. Subsequently, 100 μL binding buffer was used to resuspend the cells. After adding 5 μL of Annexin V-FITC and 1 μL of propidium iodide (PI) to the cell suspension, the mixture was incubated in darkness for 15 min at room temperature. Then, 400 μL binding buffer was added to each sample. Finally, the cells were analyzed using a flow cytometer (BDLSR, Becton Dickinson, USA).
Cell cycle detection
Cycle Test Plus
TM DNA Reagent Kit (Cat# 340242, Becton
Dickinson) was used to perform the cell cycle assay according to the manufacturer instructions. Briefly, SACC-83 and SACC-LM cells of 0 μM, 2.5 μM and 5 μM groups were collected and washed with cold PBS after exposure to SGI-1776 for 72 h. Cells were fixed in pre-cooled 70% ethanol at 4°C for 24 h. After cells were dyed with PI, flow cytometry (BDLSR, Becton Dickinson, USA) was performed to examine the cell cycle distribution.
Assessment of mitochondrial membrane potential
The fluorescent probe JC-1 (MultiSciences Company, Hangzhou, China) was employed to measure the mitochondrial membrane potential (MMP), which was recognized as a typical marker of early apoptosis. JC-1 was a lipophilic and cationic dye and it presented a fluorescence emission shift from green (525 nm) to red (590 nm), which could indicate the potential-dependent accumulation in mitochondria. Due to the low membrane potentials in healthy and normal cells, JC-1 appeared as a monocase and produced a green fluorescence. Nevertheless, J aggregates were induced by JC-1 and red fluorescence emerged at high membrane potentials. After treatment with SGI-1776 for 72 h, SACC-83 and SACC-LM cells of 0 μM, 2.5 μM and 5 μM groups were harvested by centrifugation and re-suspended in 1 mL staining buffer in accordance with the manufacturer's protocol. Then, cells were fixed with 1 μL of JC-1 staining solution and incubated at 37°C for 30 min in the dark. Subsequently, cells were washed twice with warm PBS and resuspended in 0.5 mL PBS. Flow cytometry was used to detect the red/green fluorescent signals.
Caspase-3 activity detection
Caspase-3 activity was examined using the Caspase-3 Fluorometric Assay Kit (Biovision, CA, USA). After SGI-1776 treatment, six groups of SACC cells were released with trypsin and counted. 1×10 6 cells were resuspended in 50 μL Cell Lysis Buffer for 10 min. Then, 50 μL of 2× Reaction Buffer (containing 10 mM DTT) and 5 μL of DEVD-AFC substrate were added. After incubation at 37°C for 2 h, samples were read using a Fluorescence Microplate Reader (Varioskan Flash, Thermo, USA) equipped with an excitation wavelength of 400 nm and an emission wavelength of 505 nm. Data were normalized to control samples and presented as relative caspase-3 activity.
Western blot analysis
SACC-83 and SACC-LM cells of 0 μM, 2.5 μM and 5 μM groups were harvested and lysed in RIPA Lysis Buffer (Beyotime, Nanjing, China.) supplemented with protease Inhibitor Cocktail (CWBIO, CW2383, China) after SGI-1776 treatment. Lysates were centrifuged at 12,000 g at 4°C according to the protocol. BCA Protein Assay Kit (Beyotime, Nanjing,China) was performed to measure the protein concentrations. All samples were stored at −30°C prior to use. 12% SDS-PAGE was used to separate each protein sample. After electrophoresis, the proteins were transferred from the gel to nitrocellulose membrane (Immobilon-P SQ Transfer Membrane, Millipore Corporation, Bedford, USA). Then membranes were blocked for 3 h in the TBS buffer (50 mM Tris-Cl, 150 mM NaCl, pH 7.6) containing 5% non-fat dry milk at room temperature. While the membranes of phosphorylated protein was blocked in the TBS buffer containing 5% Bovine Serum Albumin (BSA) at the same condition. Against Pim-1 (Novus biologicals, Cambridge, UK) (1:1000 dilution), FOXO3a (cell signaling technology, Boston, US) (1:1000 dilution), p-FOXO3a (p S253) (Abcam, Cambridge, UK) (1:2000 dilution), RUNX3 (Abgent, San Diego, CA, USA) (1:200 dilution), Bcl-2 (cell signaling technology, Boston, US) (1:1000), BAD (cell signaling technology, Boston, US) (1:800 dilution), p-BAD (cell signaling technology, Boston, US) (1:2000 dilution), Bim (cell signaling technology, Boston, US) (1:600 dilution), p-Bim (cell signaling technology, Boston, US) (1:1000 dilution) and GAPDH (Huabio Technology, Hangzhou, China) (1:2000 dilution) as the primary antibodies, incubating the membranes at 4°C overnight before incubation with peroxidase-labeled secondary antibodies (Huabio Technology, Hangzhou, China) at room temperature for 3 h. After that, the membranes were washed in TBST buffer ( 0.1% Tween in TBS buffer) and exposed to ECL chemiluminescence reagent. The images were captured and analyzed on the Bio-Rad GelDoc XR.
Scratch migration assay
Cell migration was assessed by scratch assay. After exposure to 0 and 5 μM SGI-1776 for 72 h, both SACC -83 and SACC-LM cells were collected and seeded onto a 6-well plate at a density of 2×10 5 cells/ml.
After an additional 48 h, a linear scratch was made on the cell monolayer with a 10-μL sterile pipette tip. "Healing" of scratch wound was recorded under microscope at 0, 8, 16 and 24 h time points.
Transwell invasion assay
After exposure to 0 and 5 μM SGI-1776 for 72 h, SACC-83 and SACC-LM cells were harvested and seeded at 1.0×10 5 cells/well in 500 μL of serum-free medium in 24-well transwell units with polycarbonate filters (8 µm pore size; Costar Inc., Milpitas, CA, USA), which was paved with the diluted matrigel(BD Matrigel TM Matrix)(1:3 diluted in RPMI-1640) in the units bottom. Meanwhile, 500 μL of RPMI-1640 medium supplemented with 10% FBS was transferred to the lower cell-free chambers. After allowing the cells to migrate for 24 h, non-migrating cells on the top surface of the membrane were gently removed and cells adhering to the bottom surface were fixed in methanol and stained with 2% crystal violet. Selecting five fields randomly under a microscope to count the invading cells.
BrdU incorporation assay
Cell growth can be evaluated by the level of DNA synthesis, which can be detected by estimating DNA incorporation of BrdU. After plating on the sterile glass covers in 6-well plate and treatment with SGI-1776 for 72 h, SACC cells of 0 μM, 2.5 μM and 5 μM groups were labeled with 80 μM BrdU and incubated in cell incubator for 80 min. Cells were then washed with PBS and fixed in 4% formaldehyde for 30 min. Subsequently, cells were incubated with BrdU primary antibody (1:100 dilution) (Sigma-Aldrich, USA) at 4°C overnight and mixed with anti-mouse IgG fluorescent secondary antibodies (Good-bio technology, Wuhan, China) at room temperature for one hour in the dark. Images were obtained using a fluorescent microscope (Olympus CX-RFL-2, Japan) under a 550 nm excitation and 590 nm emission wavelength. BrdU stained cells are represented (pseudocolored) as red, whereas BrdU unstained cells are shown in blue.
2.14. Statistical analysis SPSS 10.0 software was used to analyze all experimental data. Results of SGI-1776 investigations were represented the average of three independent experiments (mean ± standard deviations) and analyzed by the one-way analysis variance (ANOVA) statistically. p value < 0.05 was considered to be statistically significant.
Results
Pim-1 is aberrantly overexpressed in SACC tissues
The expression of Pim-1 was analyzed in 35 SACC tissue and 27 control tissues by qRT-PCR. Data showed that Pim-1 is expressed at a significantly higher level in SACC tissues than in para-cancerous histological normal tissues (p=0.015, Table 1 ).
Effect of SGI-1776 on Pim-1 protein expression and Pim-1 kinase activity in SACC-83 and SACC-LM cells
After treatment with SGI-1776, Pim-1 protein levels in SACC-83 and SACC-LM cells were measured with the help of Western blot. Pim-1 levels were significantly decreased after 2.5 μM or 5 μM of SGI-1776 exposure (Fig. 1A) . Semi-quantitative analysis of the western blots verified our results. Meanwhile, enzyme activities of Pim-1 were dramatically decreased in a dose-dependent manner after 2.5 μM or 5 μM of SGI-1776 exposure both in SACC-83 and SACC-LM cells. The Pim-1 kinase activity were (53.33 ± 7.64)%, (36.33 ± 4.51)% in SACC-83 cells and (58.67 ± 8.62)%，(40.33 ± 5.03)% in SACC-LM cells when compared with the 0 μM of SGI-1776 (assume the activity is 100%) respectively (Fig. 1B) . The difference was statistically significant among groups (p < 0.05). This revealed that SGI-1776 could inhibit Pim-1 protein expression and Pim-1 kinase activity in SACC cells.
Effect of SGI-1776 on cell proliferation and cell cycle in SACC-83 and SACC-LM cells
DNA synthesis, as examined with the 5-bromo-2′-deoxyuridine-5′-monophosphate (BrdU) incorporation assay, can reflect cellular growth. After SGI-1776 treatment, BrdU positive cells significantly decreased in both SACC cell lines, whereas control cells showed relatively higher BrdU incorporation rates ( Fig. 2A) . Furthermore, on performing colony formation assay, it was seen that the number of colonies in SACC-83 and SACC-LM cells was reduced by SGI-1776 in a dose-dependent manner (Fig. 2B) . Quantitative analysis verified our results (Fig. 2D) . Cell cycle changes were evaluated by flow cytometry 72 h after treatment of SGI-1776. In both SACC cell lines, the percentages of G0/G1 phase and G2/M phase were elevated, while the percentage of S phase was decreased in a dose-dependent manner (Fig. 2C ). There was a significant difference in the percentages of G0/ (Figs. 2E and F) . In SACC-83 cells, the percentage of cells in the S phase with 2.5 μM SGI-1776 treatment was significantly lower than that in the control group (p < 0.05) (Fig. 2E) . These data indicate that SGI-1776 could cause cell cycle arrest and reduce the proliferation of SACC cells.
Effect of SGI-1776 on cell migration and invasion
The effect of SGI-1776 on cell migration using a scratch woundhealing assay is shown in Fig. 3A . After incubation with 5 μM SGI-1776 for 72 h, the rate of wound healing in both SACC cell lines was significantly reduced when compared with control group at each time point. Additionally, the trans-well invasion assay was performed to further analyze the effect of SGI-1776 on cell migration. As shown in Fig. 3B , the invasive potential of SGI-1776 treated cells was significantly lower as compared to the control treated cells in both cell lines, with a stronger effect of SGI-1776 seen in SACC-83 cells than in SACC-LM cells. This shows that SGI-1776 can inhibit cell migration and invasiveness in both SACC-83 and SACC-LM cells.
Effect of SGI-1776 on mitochondrial function
After treatment with 2.5 μM or 5 μM SGI-1776 for 72 h, JC-1 red fluorescence was reduced whereas JC-1 green fluorescence was elevated when compared with control in both SACC cell lines (Fig. 4A) . The red/green fluorescence intensity ratio showed a significant decrease in a dose-dependent manner, presented as decreased ΔΨm (Fig. 4B) suggesting that SGI-1776 could drive mitochondrial depolarization in SACC-83 and SACC-LM cells.
Effect of SGI-1776 on apoptosis in SACC-83 and SACC-LM cells
Early-apoptosis rate (Annexin-V+/PI−) was analyzed to describe the role of SGI-1776 on apoptosis. Flow cytometry analyses showed that majority of cells in the control group were intact and alive. In the SGI-1776 treated group, apoptotic and dead cells increased considerably (Fig. 5A) . The data presented a significant increase of earlyapoptosis rate in both SACC-83 and SACC-LM cells upon treatment with SGI-1776 in a dose-dependent manner (Fig. 5B) . These data demonstrated that Pim-1 inhibition can dramatically induce apoptosis in SACC cells. In accordance with the induction of apoptosis, there was a significant increase in Caspase-3 activity in SACC-83 and SACC-LM cells following exposure of SGI-1776 for 72 h (Fig. 5C ). Caspase-3 activity was higher in SACC-LM cells than in SACC-83 cells. These results suggest that SGI-1776-induced apoptosis involves Caspase-3 activation. (Figs. 6A and B) . No significant changes were seen in the expression of FOXO3a, BAD and Bim. Semi-quantitative analysis of the western blots verified our results. Moreover, as shown in the column chart of ratios of phosphorylated-to total-protein of FOXO3a, BAD, and Bim, the ratios of phosphorylated-to total-protein of the former proteins were reduced in a dose-dependent manner.
Discussion
Elevated levels of Pim-1, a member of the serine/threonine kinase family (Pim-1, Pim-2, Pim-3), was initially discovered in human lymphoid leukemia and myeloid lymphoma tumors [24] [25] [26] . More recently, Pim-1 was found to be overexpressed in many solid tumors. A variety of studies have demonstrated that Pim-1 is an oncogene, that plays an important role in the formation, proliferation, differentiation and apoptosis of tumor cells [27, 28] . As an inhibitor of Pim-1, SGI-1776 can inhibit the biological effects of Pim-1 at a low concentration. The inhibitory action between SGI-1776 and Pim-1 had been verified in many tumors, such as urothelial carcinomas [29] , breast cancer [17] , prostate cancer [30] , acute myeloid leukemia [21] , mantle cell lymphoma [18] , chronic lymphocytic leukemia [28] , renal cell carcinoma [20] , and ovarian cancer [31] . As a result, SGI-1776 has been included in phase I clinical trials for hematological and prostate neoplasms [27] .
In the present study, we found that Pim-1 expression was significantly higher in SACC tissues than that in para-cancerous histological normal tissues. Pim-1 protein expression and Pim-1 kinase activity in both SACC-83 and SACC-LM cells was decreased significantly after SGI-1776 exposure, which demonstrated the inhibitory effect of SGI-1776 on Pim-1. The result was consistent with previously established results [17] [18] [19] [20] 27, [29] [30] [31] .
Tumor metastasis and invasion, two characteristic features of malignant cells mainly drive cancer mortality. Some research has demonstrated that silencing Pim-1 could suppress Hepatocellular carcinoma (HCC) cell invasion in vitro and decrease metastatic potential in vivo [32] . In the current study, scratch assay results suggested that on treatment with SGI-1776, the rate of SACC cell migration was significantly slower. Furthermore, invasion assay data also showed that SGI-1776 can inhibit the ability of cells to invade and pass through extracellular matrix.
Previous research on the effect of SGI-1776 on Pim-1 in ovarian cancer cells has demonstrated that down-regulation of Pim-1 expression by SGI-1776 significantly inhibits cell viability [31] . After exposure to SGI-1776, the proliferation of PDAC cells was significantly Fig. 1 . Effect of SGI-1776 on Pim-1 expression and Pim-1 kinase activity in SACC cell lines. A. Western blot showed the inhibition effect of 0, 2.5, 5 μM SGI-1776 on Pim-1 protein levels in both cell lines. Protein levels were quantified. B. Pim-1 kinase assay showed that Pim-1 activities were dramatically decreased in a dose-dependent manner after SGI-1776 treatment. The data represent the average of three independent experiments (mean ± SD). * indicated p＜0.05 vs 0 μM SGI-1776 group. lower [33] . Similar results were seen in prostate cancer cells as well [30] . BrdU incorporation and colony formation assay results showed that reduction of Pim-1 expression could restrict the cellular growth and proliferation of both SACC cell lines. These data were in sync with the CCK-8 assay result from our previous study, which displayed that SGI-1776 treatment could decrease the viability in both SACC cell lines [13] . Additionally, cell cycle analysis showed that in both SACC cell lines, the percentage of cells in the G0/G1 phase and G2/M phase were increased while the percentage of cells in the S phase was decreased in a dose-dependent manner. These data indicate that SGI-1776 could lead to cell cycle arrest, and thus reduce the proliferation and invasion of SACC cells, demonstrating the importance of Pim-1 in these processes. Pim-1 may be a valuable marker for SACC.
Apoptotic disturbance is one of the vital features of oncogenes. Mitochondria is the central organelle to regulate the apoptotic process and mitochondrial depolarization can drive pro-apoptotic protein activation and induce an amplifying cascade of caspase-3, which is the most important event in apoptosis regulation [34, 35] . In this study, Annexin-V+/PI-double staining results revealed that SGI-1776 could effectively induce apoptosis in SACC-83 and SACC-LM cells. It was found that SGI-1776 exposure could drive caspase-3 activation and mitochondrial depolarization in both SACC cell lines. Mumenthaler SM, et al. [30] reported that a gradual increase in caspase-3 activity was detected after treatment with increasing doses of SGI-1776 in prostate cancer cells. The apoptotic trend was similar in SACC and prostate cancer cells on incubation with SGI-1776.
Apoptosis is a complex process that involves a series of related proteins to ensure its proper regulation. BCL-2 is a well-known apoptotic protein family, that consists of many related proteins [36] such as Bcl-2 (anti-apoptotic factor), BAD (proapoptotic factor), Bim (proapoptotic factor) and so on. Bim has a BH3 domain which can combine with Bcl-2 and inhibit its anti-apoptotic function [37] . Besides, being a downstream target of FOXO3a, Bim induces apoptosis by direct regulation of FOXO3a [38] . Yamamura et al. [39] proved that RUNX3 in co-operation with FOXO3a stimulates the expression of Bim in gastric cancer cells. BAD, a pro-apoptotic factor, was confirmed to trigger apoptosis by binding to the Bcl-2/Bcl-X complex. Bcl-2 can restrain the mitochondrial permeability transformation and interact with pro-apoptotic proteins such as Bim and BAD in order to inactivate them. Interestingly, previous studies have considered that Pim-1 could interplay with BAD to achieve the function of Pim-1 modulating cell apoptosis [40] . They interacted with each other to achieve the function of promoting apoptosis and anti-apoptosis. FOXO3a, a pro-apoptotic transcription factor, is a substrate of Pim-1 and regulates the expression of many apoptosis-related genes [41] . Accumulated research has shown that FOXO3a plays a vital role in proliferation and apoptosis. Reports reveal that increased expression of FOXO3a could promote apoptosis, which may occur through up-regulation of the pro-apoptotic proteins like Bim [42] . The FOXO transcription factors are the targets of the PI3K-Akt signaling pathway and their activity is regulated via phosphorylation on threonine and serine residues. The phosphorylation of FOXO3a leads to its own release from DNA and translocation to the cytoplasm, resulting in self deactivation. In brief, phosphorylatedFOXO3a (p-FOXO3a), is the deactivated state of FOXO3a.
Using the Pim-1 inhibitor SGI-1776 in gradually increasing doses, we observed a decreased expression of p-FOXO3a protein, while the level of FOXO3a had no significant change. It has been shown that pFOXO3a is induced by Pim-1 [43] . In the initial part of this study, we proved that there was an obvious decrease in Pim-1 level both in SACC-83 and SACC-LM cell lines after SGI-1776 exposure. These results were coincident. Similarly, the RUNX3 protein expression gradually decreased after treatment with SGI-1776. The deactivated state of FOXO3a, p-FOXO3a was decreased which indicates that the activated state of FOXO3a was upregulated and this stimulated the expression of Bim. In this study, we found Bim protein was not significantly affected whereas p-Bim was downregulated in a dose-dependent manner. The same trend was seen for BAD and p-BAD. The activities of proapoptotic members of the Bcl-2 family, BAD and Bim were reduced by phosphorylation [44] . Our previous study suggests that FOXO3a, Bcl-2 and BAD may take part in Pim-1 related apoptosis. Bcl-2, an antiapoptotic protein, gradually decreased in both SACC-83 cell and SACC-LM cell lines after incubation with SGI-1776, which implied that apoptosis occurred on exposure to SGI-1776. All above results indicate that on reduction of Pim-1 expression by SGI-1776, a series of apoptotic events occur in SACC cells and FOXO3a, RUNX3, Bcl-2, BAD and Bim might take part in this process. In summary, our results verified the effect of SGI-1776 on Pim-1 expression, Pim-1 kinase activity and cellular events including cell proliferation, cell cycle, invasion and apoptosis of SACC cell lines. With increasing concentrations of SGI-1776, the expression of Pim-1 significantly decreased, and also the expression of p-FOXO3a and RUNX3 concomitantly decreased. Interestingly, the phosphorylated form of Bim and BAD declined with a similar trend whereas Bim and BAD did not. Taken together, our results suggest that inhibiting the expression of Pim-1 could cause cell cycle arrest, reduce proliferation, inhibit cell migration and invasion abilities, and induce apoptosis in SACC cells. Targeting Pim-1 kinase is an attractive new therapeutic strategy and a promising biomarker for SACC.
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